Skip to content
  • What we do >
    • RNA therapeutics
    • Target identification
  • Our technology >
    • The QLattice®
    • Why Abzu
    • Publications + preprints
  • About Abzu >
    • About Abzu
    • Meet the Abzoids
    • Careers
    • Investors
    • Scientific advisory board
  • News >
    • Press releases
    • Media
    • Awards
Menu
  • What we do >
    • RNA therapeutics
    • Target identification
  • Our technology >
    • The QLattice®
    • Why Abzu
    • Publications + preprints
  • About Abzu >
    • About Abzu
    • Meet the Abzoids
    • Careers
    • Investors
    • Scientific advisory board
  • News >
    • Press releases
    • Media
    • Awards
CONTACT US >

Author: Valdemar Stentoft-Hansen

Valdemar holds an MSc in Economics from University of Copenhagen and applies his experience in advanced analytics and data science to complex problems at Abzu. Valdemar still can’t take care of himself, though, and has just become a father. Good luck!

Black-box medicine is taking over. Here’s an alternative.

The increasing application of black-box models gives rise to a range of both ethical and scientific questions.

The QLattice: A new machine learning model you didn’t know you needed

Data sciencey-sphere, I have big news. A radical new machine learning model has surfaced.

  • Documentation
  • Quick start
  • Using Feyn
  • Community QLattice
  • Tutorials
  • API reference
  • FAQ
  • Community support on Discord
  • Privacy policy
  • End user license agreement
Twitter Instagram Linkedin-in